Cargando…
Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease
BACKGROUND: The EQ-5D-5 L is a commonly used generic measure of health. This study aimed to evaluate the psychometric properties of the EQ-5D-5 L in patients with Graves’ disease (GD). METHODS: A prospective cohort of patients with GD recruited at three public hospitals in Hong Kong completed the EQ...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426177/ https://www.ncbi.nlm.nih.gov/pubmed/37580816 http://dx.doi.org/10.1186/s12955-023-02177-z |
_version_ | 1785090002251677696 |
---|---|
author | Liu, Xiaodong Chan, Wendy WL Tang, Eric HM Suen, Alex HY Fung, Matrix MH Woo, Yu Cho Liu, Shirley YW Lam, Cindy LK Luo, Nan Wong, Carlos KH Lang, Brian HH |
author_facet | Liu, Xiaodong Chan, Wendy WL Tang, Eric HM Suen, Alex HY Fung, Matrix MH Woo, Yu Cho Liu, Shirley YW Lam, Cindy LK Luo, Nan Wong, Carlos KH Lang, Brian HH |
author_sort | Liu, Xiaodong |
collection | PubMed |
description | BACKGROUND: The EQ-5D-5 L is a commonly used generic measure of health. This study aimed to evaluate the psychometric properties of the EQ-5D-5 L in patients with Graves’ disease (GD). METHODS: A prospective cohort of patients with GD recruited at three public hospitals in Hong Kong completed the EQ-5D-5 L and ThyPRO-39 questionnaires at baseline, 1-month, and 6-month follow-ups. Convergent validity was tested by examining the Spearman correlation between EQ-5D-5 L and ThyPRO-39 scores at baseline. 1-month test-retest reliability was assessed by Intraclass Correlation Coefficient (ICC), Gwet’s Agreement Coefficient 2 (AC2), and percentage agreement. Responsiveness of EQ-5D-5 L index and EQ-VAS scores was assessed using effect size statistics (standardized effect size [SES] and standardized response mean [SRM]). RESULTS: Of 125 recruited patients, 101 (80.8%) and 100 (80.0%) patients were followed up at 1- and 6-month, respectively. For convergent validity, there was a moderate negative correlation between EQ-5D-5 L index or EQ-VAS score and ThyPRO-39 overall QoL-impact score (-0.350, -0.451), between EQ-VAS score and composite score (-0.483), and strong negative correlation between EQ-5D-5 L index score and composite score (-0.567). The Gwet’s AC2 and percentage agreement were the highest in self-care (0.964 and 0.967), followed by mobility (0.952 and 0.962), usual activities (0.934 and 0.948), pain/discomfort (0.801 and 0.887), and anxiety/depression (0.788 and 0.882). The ICC for the EQ-5D-5 L index and the EQ-VAS was 0.707 and 0.700. For patients who reported having ‘worsened’ health at 6-month follow-up, the SES and SRM were − 0.66 and − 0.42 for EQ-5D-5 L index and − 1.15 and − 1.00 for EQ-VAS, respectively. CONCLUSIONS: The EQ-5D-5 L demonstrated convergent validity, test-retest reliability, and responsiveness to worsened health status among patients with GD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-023-02177-z. |
format | Online Article Text |
id | pubmed-10426177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104261772023-08-16 Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease Liu, Xiaodong Chan, Wendy WL Tang, Eric HM Suen, Alex HY Fung, Matrix MH Woo, Yu Cho Liu, Shirley YW Lam, Cindy LK Luo, Nan Wong, Carlos KH Lang, Brian HH Health Qual Life Outcomes Research BACKGROUND: The EQ-5D-5 L is a commonly used generic measure of health. This study aimed to evaluate the psychometric properties of the EQ-5D-5 L in patients with Graves’ disease (GD). METHODS: A prospective cohort of patients with GD recruited at three public hospitals in Hong Kong completed the EQ-5D-5 L and ThyPRO-39 questionnaires at baseline, 1-month, and 6-month follow-ups. Convergent validity was tested by examining the Spearman correlation between EQ-5D-5 L and ThyPRO-39 scores at baseline. 1-month test-retest reliability was assessed by Intraclass Correlation Coefficient (ICC), Gwet’s Agreement Coefficient 2 (AC2), and percentage agreement. Responsiveness of EQ-5D-5 L index and EQ-VAS scores was assessed using effect size statistics (standardized effect size [SES] and standardized response mean [SRM]). RESULTS: Of 125 recruited patients, 101 (80.8%) and 100 (80.0%) patients were followed up at 1- and 6-month, respectively. For convergent validity, there was a moderate negative correlation between EQ-5D-5 L index or EQ-VAS score and ThyPRO-39 overall QoL-impact score (-0.350, -0.451), between EQ-VAS score and composite score (-0.483), and strong negative correlation between EQ-5D-5 L index score and composite score (-0.567). The Gwet’s AC2 and percentage agreement were the highest in self-care (0.964 and 0.967), followed by mobility (0.952 and 0.962), usual activities (0.934 and 0.948), pain/discomfort (0.801 and 0.887), and anxiety/depression (0.788 and 0.882). The ICC for the EQ-5D-5 L index and the EQ-VAS was 0.707 and 0.700. For patients who reported having ‘worsened’ health at 6-month follow-up, the SES and SRM were − 0.66 and − 0.42 for EQ-5D-5 L index and − 1.15 and − 1.00 for EQ-VAS, respectively. CONCLUSIONS: The EQ-5D-5 L demonstrated convergent validity, test-retest reliability, and responsiveness to worsened health status among patients with GD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-023-02177-z. BioMed Central 2023-08-15 /pmc/articles/PMC10426177/ /pubmed/37580816 http://dx.doi.org/10.1186/s12955-023-02177-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liu, Xiaodong Chan, Wendy WL Tang, Eric HM Suen, Alex HY Fung, Matrix MH Woo, Yu Cho Liu, Shirley YW Lam, Cindy LK Luo, Nan Wong, Carlos KH Lang, Brian HH Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease |
title | Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease |
title_full | Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease |
title_fullStr | Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease |
title_full_unstemmed | Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease |
title_short | Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease |
title_sort | psychometric properties of eq-5d-5l for use in patients with graves’ disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426177/ https://www.ncbi.nlm.nih.gov/pubmed/37580816 http://dx.doi.org/10.1186/s12955-023-02177-z |
work_keys_str_mv | AT liuxiaodong psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT chanwendywl psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT tangerichm psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT suenalexhy psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT fungmatrixmh psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT wooyucho psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT liushirleyyw psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT lamcindylk psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT luonan psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT wongcarloskh psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease AT langbrianhh psychometricpropertiesofeq5d5lforuseinpatientswithgravesdisease |